Immune System




The Immune System is a system that is made up from different interdependent cells.
These cells collectively protect the body from different infections that are bacterial parasitic fungal or viral and sometimes they protect from the growth of Tumor Cells.








  • Products
  • FAQ
  • References


1. Coffin J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267:483-489. [PubMed]

2. Coffin, J. M. 1996. Retroviridae: the viruses and their replication. In Fields, B. N., Knipe, D. M., and Howley, P. M., eds., Fields Virology, 3d ed., pp. 763-843. Lippincott-Raven, Philadelphia.

3. Coffman, R. L., and Beebe, A. M. 1998. Genetic control of the T cell response to Leishmania major infection. In Gupta, S., Sher, A., and Ahmed, R., eds., Mechanisms of Lymphocyte Activitation and Immune Regulation VII: Molecular Determinants of Microbial Immunity, pp. 61-66. Plenum Press, New York.

4. Cohen, S., and Lambert, P. H. 1982. Malaria. In Cohen, S., and Warren, D., eds., Immunology of Parasitic Infections, 2d ed., pp. 422-438. Blackwell, London.

5. Cole G. A., Hogg T. L., Coppola M. A., Woodland D. L. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. Journal of Immunology. 1997;158:4301-4309. [PubMed]

6. Colman, P. M. 1998. Structure and function of the neuraminidase. In Nicholson, K. G., Webster, R. G., and Hay, A. J., eds., Textbook of Influenza, pp. 65-73. Blackwell Science, Oxford.

7. Connor R. I., Sheridan K. E., Ceradini D., Choe S., Landau N. R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. Journal of Experimental Medicine. 1997;185:621-628. [PMC free article] [PubMed]

8. Connor R. J., Kawaoka Y., Webster R. G., Paulson J. C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology. 1994;205:17- 23. [PubMed]

9. Constant S. L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annual Review of Immunology. 1997;15:297-322. [PubMed]

10. Conway D. J. Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasitology Today. 1997;13:26-29. [PubMed]

11. Conway D. J., Cavanagh D. R., Tanabe K., Roper C., Mikes Z. S., Sakihama N., Bojang K. A., Oduola A. M. J., Kremsner P. G., Arnot D. E., Greenwood B. M., McBride J. S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nature Medicine. 2000;6:689-692. [PubMed]

12. Conway D. J., Roper C., Oduola A. M. J., Arnot D. E., Kremsner P. G., Grobusch M. P., Curtis C. F., Greenwood B. M. High recombination rate in natural populations of Plasmodium falciparum. Proceedings of the National Academy of Sciences USA. 1999;96:4506-4511. [PMC free article] [PubMed]

13. Cooper L. A., Scott T. W. Differential evolution of eastern equine encephalitis virus populations in response to host cell type. Genetics. 2001;157:1403-1412. [PMC free article] [PubMed]

14. Cornelissen M., Kampinga G., Zorgdrager F., Goudsmit J. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. Journal of Virology. 1996;70:8209-8212. [PMC free article] [PubMed]

15. Couceiro J. N., Paulson J. C., Baum L. G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: the role of the host cell in selection of hemagglutinin receptor specificity. Virus Research. 1993;29:155- 165. [PubMed]

16. Cowell L., Kepler T. B., Janitz M., Lauster R., Mitchison N. A. The distribution of variation in regulatory gene segments as present in MHC class II promoters. Genome Research. 1998;8:124-134. [PubMed]

17. Cox N. J., Bender C. A. The molecular epidemiology of influenza viruses. Seminars in Virology. 1995;6:359-370.

18. Cox N. J., Subbarao K. Global epidemiology of influenza: past and present. Annual Review of Medicine. 2000;51:407-421. [PubMed]

19. Crandall, K. A., ed. 1999. The Evolution of HIV. Johns Hopkins University Press, Baltimore, Maryland.

20. Crill W. D., Wichman H. A., Bull J. J. Evolutionary reversals during viral adaptation to alternating hosts. Genetics. 2000;154:27-37. [PMC free article] [PubMed]

21. Croft M., Swain S. L. Analysis of CD4+ T cells that provide contact-dependent bystander help to B cells. Journal of Immunology. 1992;149:3157-3165. [PubMed]

22. Crow, J. F., and Kimura, M. 1970. An Introduction to Population Genetics Theory. Burgess, Minneapolis, Minnesota.

23. Daser A., Mitchison H., Mitchison A., Muller B. Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes. Cytokine. 1996;8:593-597. [PubMed]

24. Davis M. M., Boniface J. J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by ab T cell receptors. Annual Review of Immunology. 1998;16:523- 544. [PubMed]

25. de Lana M., da Silveira A., Bastrenta B., Barnabe C., Noel S., Tibayrenc M. Trypanosoma cruzi: infectivity of clonal genotype infections in acute and chronic phases in mice. Experimental Parasitology. 2000;96:61-66. [PubMed]

26. Deitsch K. W., Moxon E. R., Wellems T. E. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiology and Molecular Biology Reviews. 1997;61:281-293. [PMC free article] [PubMed]

27. Deitsch K. W., Wellems T. E. Membrane modifications in erythrocytes parasitized by Plasmodium falciparum. Molecular and Biochemical Parasitology. 1996;76:1- 10. [PubMed]

28. del Portillo H. A., Fernandez-Becerra C., Bowman S., Oliver K., Preuss M., Sanchez C. P., Schneider N. K., Villalobos J. M., Rajandream M.-A., Harris D., Perera da Silva L. H., Barrell B., Lanzer M. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature. 2001;410:839-842. [PubMed]

29. Deng Y., Yewdell J. W., Eisenlohr L. C., Bennink J. R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I- restricted peptides recognized by antiviral CTL. Journal of Immunology. 1997;158:1507- 1515. [PubMed]

30. Dick L. R., Aldrich C., Jameson S. C., Moomaw C. R., Pramanik B. C., Doyle C. K., Demartino G. N., Bevan M. J., Forman J. M., Slaughter C. A. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to yield antigenic peptides. Journal of Immunology. 1994;152:3884-3894. [PMC free article] [PubMed]

31. Dimmock N. J. Neutralization of animal viruses. Current Topics in Microbiology and Immunology. 1993;183:1-149. [PubMed]

32. Dimmock N. J. Update on the neutralization of animal viruses. Reviews in Medical Virology. 1995;5:165-179.

33. Doherty P. C., Biddison W. E., Bennink J. R., Knowles B. B. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. Journal of Experimental Medicine. 1978;148:534-543. [PMC free article] [PubMed]

34. Doherty P. C., Christensen J. P. Accessing complexity: the dynamics of virus-specific T cell responses. Annual Review of Immunology. 2000;18:561-592. [PubMed]

35. Dougan D. A., Malby R. L., Gruen L. C., Kortt A. A., Hudson P. J. Effects of substitutions in the binding surface of an antibody on antigen affinity. Protein Engineering. 1998;11:65-74. [PubMed]

36. Dowdle W. R. Influenza A virus recycling revisited. Bulletin of the World Health Organization. 1999;77:820-828. [PMC free article] [PubMed]

37. Drake J. W., Charlesworth B., Charlesworth D., Crow J. F. Rates of spontaneous mutation. Genetics. 1998;148:1667-1686. [PMC free article] [PubMed]

38. Drake J. W., Holland J. J. Mutation rates among RNA viruses. Proceedings of the National Academy of Sciences USA. 1999;96:13910-13913. [PMC free article] [PubMed]

39. Drescher J., Aron R. Influence of the amino acid differences between the hemagglutinin HA1 domains of influenza virus H1N1 strains on their reaction with antibody. Journal of Medical Virology. 1999;57:397-404. [PubMed]

40. Dutton R. W., Bradley L. M., Swain S. L. T cell memory. Annual Review of Immunology. 1998;16:201-223. [PubMed]

41. Earn D. J. D., Rohani P., Bolker B. M., Grenfell B. T. A simple model for complex dynamical transitions in epidemics. Science. 2000;287:667-670. [PubMed]

42. Edfors-Lilja I., Wattrang E., Marklund L., Moller M., Andersson-Eklund L., Andersson L., Fossum C. Mapping quantitative trait loci for immune capacity in the pig. Journal of Immunology. 1998;161:829-835. [PubMed]

43. Edwards M. J., Dimmock N. J. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition. Virology. 2000;278:423-435. [PubMed]

44. El-Omar E. M., Carrington M., Chow W.-H., McColl K. E. L., Bream J. H., Young H. A., Herrera J., Lissowska J., Yuan C.-C., Rothman N., Lanyon G., Martin M., Fraumeni J. F. Jr, Rabkin C. S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402. [PubMed]

45. Endo T., Ikeo K., Gojobori T. Large-scale search for genes on which positive selection may operate. Molecular Biology and Evolution. 1996;13:685-690. [PubMed]

46. Engelhard V. H., Lacy E., Ridge J. P. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. Journal of Immunology. 1991;146:1226-1232. [PubMed]

47. Enright M. C., Spratt B. G. Multilocus sequence typing. Trends in Microbiology. 1999;7:482-487. [PubMed]

48. Evans D. T., O'Connor D. H., Jing P., Dzuris J. L., Sidney J., da Silva J., Allen T. M., Horton H., Venham J. E., Rudersdorf R. A., Vogel T., Pauza C. D., Bontrop R. E., DeMars R., Sette A., Hughes A. L., Watkins D. I. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nature Medicine. 1999;5:1270-1276. [PubMed]

49. Farber D. L. T cell memory: heterogeneity and mechanisms. Clinical Immunology. 2000;95:173-181. [PubMed]

50. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J. C., Strazzera A., Chien D. Y., Munoz S. J., Balestrieri A., Purcell R. H., Alter H. J. The outcome of acute hepatitis C predicted by the evolution of viral quasispecies. Science. 2000;288:339- 344. [PubMed]

51. Fazekas de St. Groth S., Webster R. G. Disquisitions on original antigenic sin. I. Evidence in man. Journal of Experimental Medicine. 1966a;124:331-345. [PMC free article] [PubMed]

52. Fazekas de St. Groth S., Webster R. G. Disquisitions on original antigenic sin. II. Proof in lower creatures. Journal of Experimental Medicine. 1966b;124:347-361. [PMC free article] [PubMed]

53. Feavers I. M., Fox A. J., Gray S., Jones D. M., Maiden M. C. J. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clinical and Diagnostic Laboratory Immunology. 1996;3:444-450. [PMC free article] [PubMed]

54. Feigelstock D. A., Mateu M. G., Valero M. L., Andreu D., Domingo E., Palma E. L. Emerging foot-and-mouth disease virus variants with antigenically critical amino acid substitutions predicted by model studies using reference viruses. Vaccine. 1996;14:97- 102. [PubMed]

55. Ferguson N., Anderson R., Gupta S. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proceedings of the National Academy of Sciences USA. 1999;96:790-794. [PMC free article] [PubMed]

56. Fischetti V. A. Streptococcal M protein. Scientific American. 1991;264(6):32- 39. [PubMed]

57. Fish S., Zenowich E., Fleming M., Manser T. Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response. Journal of Experimental Medicine. 1989;170:1191-1209. [PMC free article] [PubMed]

58. Fleury D., Barr�re B., Bizebard T., Daniels R. S., Skehel J. J., Knossow M. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nature Structural Biology. 1999;6:530-534. [PubMed]

59. Fleury D., Wharton S. A., Skehel J. J., Knossow M., Bizebard T. Antigen distortion allows influenza virus to escape neutralization. Nature Structural Biology. 1998;5:119- 123. [PubMed]

60. Forsyth K. P., Philip G., Smith T., Kum E., Southwell B., Brown G. V. Diversity of antigens expressed on the surface of the erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea.